Combining PD-1inhibitor with VEGF inhibitor in chemotherapy of cholangiocarcinoma patient

(Bentham Science Publishers) Cholangiocarcinoma is the second most frequent liver cancer. Many patients miss the opportunity of having a surgery performed on them and its control has always been considered difficult. Here, doctors from The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China, present a case of stage 4 cholangiocarcinoma.